Patents by Inventor Sabine Haag

Sabine Haag has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibacterial Compounds Produced by the Microorganism Strain Corallococcus Coralloides ST201330 (DSM 24989)
    Publication number: 20200216496
    Abstract: The present invention relates to novel compounds of the formula (I), in which R is is hydrogen or hydroxy, that can be obtained by fermentation of the microorganism strain Corallococcus coralloides ST201330 (DSM 24989).
    Type: Application
    Filed: September 17, 2018
    Publication date: July 9, 2020
    Inventors: Heike Stump, Luigi Toti, Michael Kurz, Sabine Haag Richter, Diertmar Schummer
  • Bengamide derivatives, process for preparing them, and their use
    Patent number: 7638320
    Abstract: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898).
    Type: Grant
    Filed: November 2, 2006
    Date of Patent: December 29, 2009
    Assignee: sanofi-aventis Deutschland GmbH
    Inventor: Sabine Haag-Richter
  • Bengamide derivatives, process for preparing them, and their use
    Patent number: 7534591
    Abstract: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898).
    Type: Grant
    Filed: November 2, 2006
    Date of Patent: May 19, 2009
    Assignee: sanofi-aventis Deutschland GmbH
    Inventors: Holger Hoffmann, Sabine Haag-Richter, Heiko Tietgen
  • BENGAMIDE DERIVATIVES, PROCESS FOR PREPARING THEM, AND THEIR USE
    Publication number: 20070065929
    Abstract: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898).
    Type: Application
    Filed: November 2, 2006
    Publication date: March 22, 2007
    Applicant: Sanofi-aventis Deutschland GmbH
    Inventors: Holger HOFFMANN, Sabine HAAG-RICHTER, Michael KURZ, Heiko TIETGEN
  • BENGAMIDE DERIVATIVES, PROCESS FOR PREPARING THEM, AND THEIR USE
    Publication number: 20070065932
    Abstract: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898).
    Type: Application
    Filed: November 2, 2006
    Publication date: March 22, 2007
    Applicant: Sanofi-aventis Deutschland GmbH
    Inventors: Holger HOFFMANN, Sabine HAAG-RICHTER, Michael Kurz, Heiko Tietgen
  • Bengamide derivatives, process for preparing them, and their use
    Patent number: 7153846
    Abstract: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898)
    Type: Grant
    Filed: October 22, 2004
    Date of Patent: December 26, 2006
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Holger Hoffmann, Sabine Haag-Richter, Michael Kurz, Heiko Tietgen
  • Endiandric acid H and its derivatives, process for their preparation and use thereof
    Patent number: 7019028
    Abstract: The invention relates to compounds of the formula (I) process for their preparation starting from the plant Beilschmiedia fulva, PLA 101037, and the use thereof for producing a medicament, in particular for the treatment of allergic disorders, of asthmatic disorders, of inflammatory concomitant symptoms of asthma and/or of diseases which can be treated by inhibiting c-maf and NFAT.
    Type: Grant
    Filed: July 25, 2003
    Date of Patent: March 28, 2006
    Assignees: Aventis Pharma Deutschland GmbH, Aventis Pharmaceuticals Inc.
    Inventors: Claudia Eder, Herbert Kogler, Sabine Haag-Richter
  • Polyisoprenylbenzophenone derivatives, processes for their preparation and use thereof
    Patent number: 6956061
    Abstract: The present invention relates to compounds of the formula (I): which are produced by the plant Garcinia punctata, chemical derivatives derived therefrom, a process for their preparation, and their use as pharmaceuticals, in particular for the treatment and/or prophylaxis of bacterial infectious diseases.
    Type: Grant
    Filed: July 31, 2003
    Date of Patent: October 18, 2005
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Matthias Schiell, Michael Kurz, Sabine Haag-Richter
  • Bengamide derivatives, process for preparing them, and their use
    Publication number: 20050171089
    Abstract: The present invention relates to bengamide derivatives which are formed, during fermentation, by the microorganism Myxococcus virescens ST200611 (DSM 15898), to their use for treating cancer diseases, to pharmaceuticals which comprise bengamide derivatives, to a process for preparing bengamides of the formula (V) and to the microorganism Myxococcus virescens ST200611 (DSM 15898).
    Type: Application
    Filed: October 22, 2004
    Publication date: August 4, 2005
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Holger Hoffmann, Sabine Haag-Richter, Michael Kurz, Heiko Tietgen
  • Endiandric acid H and its derivatives, process for their preparation and use thereof
    Publication number: 20040138313
    Abstract: The invention relates to compounds of the formula (I) 1
    Type: Application
    Filed: July 25, 2003
    Publication date: July 15, 2004
    Applicant: Aventis Pharma Deutschland GmbH
    Inventors: Claudia Eder, Herbert Kogler, Sabine Haag-Richter
  • Polyisoprenylbenzophenone derivatives, processes for their preparation and use thereof
    Publication number: 20040082662
    Abstract: The present invention relates to compounds of the formula (I) 1
    Type: Application
    Filed: July 31, 2003
    Publication date: April 29, 2004
    Applicant: Aventis Pharma Deutschland Gmbh
    Inventors: Matthias Schiell, Michael Kurz, Sabine Haag-Richter
  • Klainetins and their derivatives, method for their preparation and use thereof
    Patent number: 6579903
    Abstract: The invention relates to compounds of formula I and of formula II in which R1, R2, R3, R4, R5, X1, X2, X3, X4, X5 and Y are defined in the specification. The compounds of formulae I and II inhibit cyclin-dependent kinases (CDKS) and other kinases (KDR), have cytostatic actions, and are suitable for treating tumors. The compounds of formulae I and II are obtainable by extracting the plant Uvaria klaineri, PLA 100484, by cell cultures of the plant Uvaria klaineri, or by chemical synthesis. The invention relates to a method for preparing the compounds of formulae I and II, to the use of the compounds for producing a pharmaceutical for the treatment of malignant disorders and of diseases which may be treated by inhibition of CDKs and KDR, and also to pharmaceutical compositions comprising at least one compound of the formula I or II.
    Type: Grant
    Filed: December 4, 2001
    Date of Patent: June 17, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Sabine Haag, Herbert Kogler, Ziyu Li, Laszlo Vertésy
  • Klainetins and their derivatives, method for their preparation and use thereof
    Publication number: 20020103389
    Abstract: The invention relates to compounds of formula I 1
    Type: Application
    Filed: December 4, 2001
    Publication date: August 1, 2002
    Inventors: Sabine Haag, Herbert Kogler, Ziyu Li, Laszlo Vertesy